DE2344451C2 - 7-[β-Aminoacylamino]-3-substituierte-3-cephem-4-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel - Google Patents

7-[β-Aminoacylamino]-3-substituierte-3-cephem-4-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel

Info

Publication number
DE2344451C2
DE2344451C2 DE2344451A DE2344451A DE2344451C2 DE 2344451 C2 DE2344451 C2 DE 2344451C2 DE 2344451 A DE2344451 A DE 2344451A DE 2344451 A DE2344451 A DE 2344451A DE 2344451 C2 DE2344451 C2 DE 2344451C2
Authority
DE
Germany
Prior art keywords
cephem
carboxylic acid
methyl
substituted
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2344451A
Other languages
German (de)
English (en)
Other versions
DE2344451A1 (de
Inventor
Masaru Takatsuki Kurita
Osamu Sakai Nishiwaki
Kunihiko Toyonaka Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP11598372A external-priority patent/JPS5725557B2/ja
Priority claimed from JP1863673A external-priority patent/JPS563878B2/ja
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of DE2344451A1 publication Critical patent/DE2344451A1/de
Application granted granted Critical
Publication of DE2344451C2 publication Critical patent/DE2344451C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
DE2344451A 1972-11-17 1973-09-04 7-[β-Aminoacylamino]-3-substituierte-3-cephem-4-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel Expired DE2344451C2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11598372A JPS5725557B2 (enExample) 1972-11-17 1972-11-17
JP1863673A JPS563878B2 (enExample) 1973-02-14 1973-02-14

Publications (2)

Publication Number Publication Date
DE2344451A1 DE2344451A1 (de) 1974-05-30
DE2344451C2 true DE2344451C2 (de) 1983-02-03

Family

ID=26355341

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2344451A Expired DE2344451C2 (de) 1972-11-17 1973-09-04 7-[β-Aminoacylamino]-3-substituierte-3-cephem-4-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel

Country Status (7)

Country Link
CA (1) CA1032534A (enExample)
CH (1) CH589658A5 (enExample)
DE (1) DE2344451C2 (enExample)
FR (1) FR2206934B1 (enExample)
GB (1) GB1438872A (enExample)
NL (1) NL7312366A (enExample)
SE (1) SE415019B (enExample)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3518260A (en) * 1965-03-08 1970-06-30 Lilly Co Eli Method for preparing aminoacyl cephalosporins
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds

Also Published As

Publication number Publication date
FR2206934B1 (enExample) 1977-01-28
CH589658A5 (enExample) 1977-07-15
CA1032534A (en) 1978-06-06
SE415019B (sv) 1980-09-01
FR2206934A1 (enExample) 1974-06-14
GB1438872A (en) 1976-06-09
NL7312366A (enExample) 1974-05-21
DE2344451A1 (de) 1974-05-30

Similar Documents

Publication Publication Date Title
AT380472B (de) Verfahren zur herstellung von neuen 3-amino-beta-lactam-1-sulfonsaeuren und ihren salzen
CH630632A5 (de) Verfahren zur herstellung neuer cephalosporinderivate.
DE2710282C2 (de) 3,7-disubstituierte-3-Cephem-4- carbonsäureverbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzung
DE2129675B2 (de) 7-Methoxycephalosporinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2415402C2 (de) Cephalosporansäurederivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
DE2824559A1 (de) 7 alpha -methoxy-7 beta-(1,3- dithietan-2-carboxamido)cephalosporansaeurederivate und verfahren zu ihrer herstellung
DE2225694A1 (de) Cephalosporinverbindungen und Ver fahren zu deren Herstellung
DE2826546C2 (enExample)
DE3130404C2 (enExample)
CH636879A5 (de) Verfahren zur herstellung 7-substituierter aminoacetamido-oxadethia-cephalosporine.
EP0000392A2 (de) Cephalosporin und Penicillin-derivate, Verfahren zu deren Herstellung, und deren pharmazeutische Präparate
CH640539A5 (de) Verfahren zur herstellung von neuen cephemcarbonsaeurederivaten.
DE2539411A1 (de) Cephamycine, ihre salze, verfahren zu ihrer herstellung und arzneipraeparate
DE2715038A1 (de) Neue antibakterielle verbindungen
CH647524A5 (de) 7alpha-methoxycephalosporine und verfahren zur herstellung derselben.
EP0035161B1 (de) Cephalosporine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2927462A1 (de) Cephalosporin-1,1-dioxide, ihre herstellung und ihre verwendung
DE69816057T2 (de) Antibakterielle substituierte 7-acylamino-3-(methylhydrazono)methyl-cephalosporine und zwischenprodukte
DE3035259A1 (de) Cephalosporinverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2442702C2 (de) Cephalosporinverbindungen, Verfahren zu ihrer Herstellung und antibakterielle Mittel, die diese Verbindungen enthalten
DE2236422C2 (de) Cephalosporinverbindungen und Verfahren zu deren Herstellung
EP0054677B1 (de) Neue Cephalosporine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2927683A1 (de) Neue cephalosporinderivate, verfahren zu ihrer herstellung sowie arzneimittel
DE2722666C2 (de) 7-Acylamino-3-pyrazinylthiomethyl- 3-cephem-4-carbonsäure-Verbindungen und ihre Verwendung/Bekämpfung bakterieller Infektionen
CH648035A5 (de) Cephalosporin-analoge, verfahren zu ihrer herstellung und sie enthaltendes arzneimittel.

Legal Events

Date Code Title Description
OD Request for examination
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee